- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07261852
Muscle Strength Training in Lower Limb Amputee Patients
Effects of Muscle Strength Training in Lower Limb Amputee Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gabriela B Dell´Elce
- Phone Number: +54 3462344478
- Email: gdellelce@ugr.edu.ar
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with unilateral lower limb amputation
- Transtibial and/or transfemoral amputation
- Prosthetized
- Aged 18 to 75 years
- Who sign the informed consent form
Exclusion Criteria:
- That they are unable to complete the initial assessment
- That they undergo further secondary training
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Muscle strength training
Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained. |
Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained. |
|
Active Comparator: Endurance training
Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM.
|
Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Funcionality
Time Frame: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is assessed using the TUG test, which requires patients to get up from a chair, walk 3 meters, turn around, walk back to the chair, and sit down again.
Patients will receive the following instructions: "Get up on the word 'go,' walk to the tape, turn around, walk back to the chair, and sit down."
|
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
|
Changes in quality of life
Time Frame: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is assessed using a self-administered questionnaire called WHOQOL-BREF, which provides a profile of the person's perceived quality of life.
|
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Maximum isometric muscle strength
Time Frame: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is evaluated using a dynamometer, in which three measurements are taken for each designated movement and the average of the maximum force and peak force is calculated.
|
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
|
Changes on Movility
Time Frame: day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
It is assessed using the AMP functional rating scale (amputee mobility predictor).
|
day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.
|
|
Change in Global percepcion of change
Time Frame: assessments were performed at the end each protocol. day 18 and day 24
|
It is an assessment carried out using the Groc scale, which evaluates changes in perception.
|
assessments were performed at the end each protocol. day 18 and day 24
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Mauro S Barone, Ugr
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 619/2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Limb Amputation
-
University of Nevada, Las VegasUnited States Department of Defense; National Institutes of Health (NIH); University... and other collaboratorsRecruitingLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Amputation | Lower Limb Amputation Knee | Lower Limb Amputation at Ankle (Injury) | Lower Limb Amputation at Hip (Injury)United States
-
Otto Bock Healthcare Products GmbHHanger Clinic: Prosthetics & OrthoticsActive, not recruitingLower Limb Amputation Above Knee (Injury) | Lower Limb Amputation Knee | Congenital Amputation of Lower LimbUnited States
-
Sint MaartenskliniekCompletedLower Limb Amputation Above Knee (Injury) | Lower Limb Amputation KneeNetherlands
-
Campus Bio-Medico UniversityFondazione Don Carlo Gnocchi OnlusRecruitingLower Limb Amputation Below Knee | Lower Limb Amputation Above KneeItaly
-
Otto Bock France SNCRecruitingLower Limb Amputation Below Knee | Lower Limb Amputation Above KneeFrance
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Amputation | Behavior | Lower Limb Amputation KneeCanada
-
Tezel Yıldırım ŞahanCompletedValidity and Reliability of The 3-Meter Backward Walk Test in Individuals With Lower Limb AmputationLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation KneeTurkey
-
Uskudar UniversityActive, not recruitingAmputation | Lower Limb AmputationTurkey (Türkiye)
-
Sint MaartenskliniekCompletedAmputation | Lower Limb AmputationNetherlands
-
Otto Bock Healthcare Products GmbHCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Lower Limb Amputation KneeUnited States
Clinical Trials on Muscle strengh training
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University of FloridaCompleted
-
National Taiwan University HospitalNot yet recruitingParkinson Disease | Pulmonary Disease | Voice Disorders
-
Ceren Derya GültekinRecruitingPulmonary Rehabilitation | Inspiratory Muscle Training | Hematopoietic Stem Cell Transplantation (HSCT)Turkey
-
Biruni UniversityRecruiting
-
Universidade Federal de PernambucoCompletedMuscular Atrophy | Aging | Sensitivity Training GroupsBrazil
-
Faculdade de Ciências Médicas da Santa Casa de...Completed
-
University of the State of Santa CatarinaCompletedHeart Diseases | Cardiovascular Diseases | Coronary Disease | Coronary Artery Occlusion
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Riphah International UniversityRecruitingPronation Distotion SyndromePakistan